# 18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma

> **NCT01169350** · PHASE2 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 8 (actual)

## Conditions studied

- Recurrent Adult Soft Tissue Sarcoma
- Stage I Adult Soft Tissue Sarcoma
- Stage II Adult Soft Tissue Sarcoma
- Stage III Adult Soft Tissue Sarcoma
- Stage IV Adult Soft Tissue Sarcoma

## Interventions

- **RADIATION:** fludeoxyglucose F 18
- **OTHER:** 18F-fluoromisonidazole
- **PROCEDURE:** positron emission tomography
- **PROCEDURE:** computed tomography
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01169350
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2011-10
- **Final completion:** 2013-08
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** funding source ended earlier than anticipated
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01169350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01169350, "18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01169350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*